Abstract
Oral Administration of Mavorixafor, a CXCR4 Antagonist, Increases Peripheral White Blood Cell Counts across Different Disease States
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1182/blood-2021-152990
Copy DOIJournal: Blood | Publication Date: Nov 5, 2021 |
Citations: 2 |
Oral Administration of Mavorixafor, a CXCR4 Antagonist, Increases Peripheral White Blood Cell Counts across Different Disease States
Join us for a 30 min session where you can share your feedback and ask us any queries you have